Market News

A proposal to include personal stories in a government database of consumer complaints is drawing comparisons to Yelp and Angie's List -- and not in a good way. The Consumer Financial Protection Bureau first began sharin...

For the first time, an international bank is being held responsible for supporting a terrorist group in a civil suit under the Anti-Terrorism Act. The guilty verdict for Arab Bank in a federal court in New York on Monday...

Critics are calling on European policymakers to impose harsher rules to limit the import of conflict minerals, using their American counterparts as an example. "There's good reason to believe European companies are profi...

Talk about biting the hand that feeds you. After the biggest corporate bailout in history, when the U.S. government committed $182 billion to rescue AIG as it teetered on the verge of bankruptcy, the insurance giant's fo...

Several regulators haven't appointed independent full-time chief vigilance officers

A look at the impact on key coal-dependent sectors and how CIL becomes an indirect beneficiary of cancellations

When hedge fund manager "titans" think alike, investors are wise to pay attention. At Holdings Channel, we have reviewed 3,749 13F filings for the 06/30/2014 reporting period, and noticed that Actavis (NYSE: ACT) was hel...

At Holdings Channel, we have reviewed 3,749 13F filings for the 06/30/2014 reporting period, and looked at the various S&P 500 components held by each of these reporting hedge funds and other 13F filers. For each compone...

The best performing sector as of midday Wednesday is the Healthcare sector, higher by 1.3%. Within that group, Vertex Pharmaceuticals (NASD: VRTX) and Alexion Pharmaceuticals (NASD: ALXN) are two of the day's stand-outs,...

In our opinion, the transaction will not have any material impact on Walgreen's financials and valuation. The Infusion Services business of Walgreen has EBITDA of around $105 million, which accounts for less than 3% of t...

In the first half of 2014, Southwest Airlines has posted impressive growth in its profits on strong demand for air travel in the domestic U.S. market. Even though the low-cost carrier has not raised its flying capacity t...

Yale University's endowment reported a 20.2% investment return for fiscal 2014, a result that bested Harvard University and other Ivy League rivals.

The move marks yet another step by Goldman Sachs to grow its asset management business as it looks to increase the share of less volatile revenue streams in its business model amid increasing regulatory pressure to downs...

We figure Textron is poised for solid top line growth in the near term driven by rising global demand for its Bell commercial helicopters and growing sales of its industrial products from the emerging countries. On the f...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to ...

Accenture has declared a semi-annual cash dividend of $1.02 per share on Accenture Class A ordinary shares for shareholders of record at the close of business on Oct. 17, 2014, and Accenture SCA will declare a semi-annua...

The Guggenheim China Small Cap ETF (HAO) is seeing unusually high volume in afternoon trading Wednesday, with over 227,000 shares traded versus three month average volume of about 63,000.  Shares of HAO were up about 0....

In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.7% on the day.  Components of that ETF showing particular strength include shares of Acorda Therapeutics (ACOR), up about 2...

In trading on Wednesday, general contractors & builders shares were relative laggards, down on the day by about 1.3%.  Helping drag down the group were shares of KB Home (KBH), down about 5.4% and shares of Taylor Morri...

In trading on Wednesday, drugs shares were relative leaders, up on the day by about 1.6%.  Leading the group were shares of Lipocine (LPCN), up about 44.1% and shares of Loxo Oncology (LOXO) up about 8.9% on the day.

Investors eyeing a purchase of Teradata Corp (NYSE: TDC) shares, but cautious about paying the going market price of $43.03/share, might benefit from considering selling puts among the alternative strategies at their dis...

Investors considering a purchase of Ventas, Inc. (NYSE: VTR) stock, but cautious about paying the going market price of $61.26/share, might benefit from considering selling puts among the alternative strategies at their ...